UniSA scientists make a surprising discovery in the origins of antibiotic-resistant gene

University of South Australia scientists have made a surprising discovery in the origins of an antibiotic-resistant gene previously thought to have been confined to Adelaide.

UniSA scientists make a surprising discovery in the origins of antibiotic-resistant gene
Pseudomonas aeruginosa, an organism responsible for thousands of deaths. Image Credit: University of South Australia

The gene, first detected in Adelaide in 2006, is carried by the nasty bacterium Pseudomonas aeruginosa, an organism responsible for thousands of deaths among immunocompromised, surgical and burns patients due to its resistance to last resort antibiotics.

This gene makes infections resistant to the most potent antibiotics used in medicine – imipenem and meropenem. Antibiotic resistant P. aeruginosa is now listed by the World Health Organization as a “critical priority pathogen”, one of 12 families of bacteria that pose the greatest threat to human health.

Until now, it was believed that the Adelaide Imipenemase (AIM-1) gene was only found in the South Australian capital city after being detected in clinical samples and healthcare-associated wastewater.

But a group of scientists led by UniSA microbiologist Associate Professor Rietie Venter has shown evidence of it worldwide, pinpointing its source in a harmless environmental organism present in soil, groundwater, wastewater and even in plants.

The findings have been published in the journal Microbial Genomics.

The discovery suggests that the gene has mobilized at some stage and jumped from a harmless organism to a nasty pathogen.

“It’s an opportunistic pathogen which is ubiquitous and very resilient,” says Assoc Prof Venter.

The team used innovative ways to track and characterize antimicrobial resistance, making their discovery through wastewater analysis. Their research revealed the AIM-1 gene was prevalent at many sites throughout Adelaide and South Australia, including in every wastewater sample and river water, hinting at a wider spread of the gene than originally thought.

We then investigated the possibility of a global distribution of the AIM-1 gene. Through extensive nucleotide and protein data base searching, we discovered the gene was also present in Asia, North America and Europe.”

Rietie Venter, Associate Professor and UniSA Microbiologist

However, AIM-1 was predominantly found in harmless environmental organisms and has only made the jump to the pathogen P. aeruginosa in two other locations so far (Iran and Iraq).

“Genes that are ‘mobile’ jump around all the time, but the scenario described in this study is much rarer,” says Assoc Prof Venter.

“However, as microbes are a great source of antibiotics and very competitive, it is highly likely that many bacterial resistant genes evolve in unknown organisms before making their way to dangerous pathogens, especially P. aeruginosa, which shares a habitat with harmless environmental organisms.”  

Assoc Prof Venter says the AIM-1 gene requires carefully monitoring.

“If we can better understand why genes jump from environmental into human pathogens, we might be able to prevent it from happening more often,” she says.

Source:
Journal reference:

Amsalu, A., et al. (2021) Worldwide distribution and environmental origin of the Adelaide imipenemase (AIM-1), a potent carbapenemase in Pseudomonas aeruginosa. Microbial Genomics. doi.org/10.1099/mgen.0.000715.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Engineered virus-like particles evolve for superior gene delivery efficiency